Location
Headquarters: Skillman, New Jersey, United States, North America
Region: New Jersey
Country: US
Continent: North America
About
Kenvue is a global leader in consumer health, owning iconic brands and delivering everyday care with scientific precision. The company touches the lives of billions worldwide, operating across categories from oral and skin health to daily wellness and personal care. Rooted in science and supported by healthcare professionals, Kenvue focuses on bringing purposeful innovations to communities, homes, and hands at every stage of life. Headquartered with a worldwide reach, the company emphasizes sustainability and responsible leadership as it grows its portfolio of trusted brands.
Kenvue is a global consumer health company that manufactures and sells over-the-counter medicines and personal care products. Its portfolio includes well-known brands such as Tylenol, Neutrogena, Listerine, and Johnson's, serving consumers seeking everyday wellness and hygiene solutions. The company operates independently following its spin-off from Johnson & Johnson.
Kenvue Inc.
2023
for_profit
active
Industries
Primary Industry: Manufacturing
Categories
Funding & Financials
Public Company
3800000000
over-1b
ipo
NYSE:KVUE
nasdaq
Investors
Founders
Thibaut Mongon
Leadership
Technology Stack
Products
Tylenol: An over-the-counter pain relief and cold & cough medication used to reduce pain and fever.
Listerine: An antiseptic mouthwash designed to reduce plaque, kill germs, and improve oral hygiene.
Neutrogena: A brand offering products for face care, body care, hair care, sun care, and cosmetics focused on skin health.
Johnson’s Baby: A line of baby care products including skin and hair care formulated for infants and young children.
Aveeno: A brand providing baby care, face care, body care, hair care, sun care, and cosmetics focused on skin health.
Motrin: An over-the-counter pain relief medication used to reduce inflammation, pain, and fever.
Funding rounds
Acquired · (2025-11-03)
Post Ipo Equity · (2025-04-25) · Lead: Third Point
Post Ipo Equity · (2024-10-21) · Lead: Starboard Value
